Joseph Colleluori will Join Our Board of Directors
March 22nd, 2022
Global pharma CDMO Escientia is delighted to announce that Joseph Colleluori will join our board of directors.
Joe brings with him extensive experience in strategy and acquisition in the pharma world having spearheaded many successful projects at Merck & Co and Lonza as an executive in diverse senior roles for over 25 years.
Commenting on the announcement, Dr Yadagiri Pendri, CEO and Marcel Velterop, Co-CEO of Escientia, stated: “We are very privileged to be able to have Joe join our board and help us embrace exceptional life for patients, building powerful sustainable partnerships with pharma biotechs and large innovators.”
Joe Colleluori commented: “Exciting times to be joining the Escientia board as they prepare for rapid growth and entry into new areas of innovation helping fuel an exceptional life services provider. I am personally happy to join a great organization such as Escientia and look forward to working with management to hone and advance their ambitious growth plans.”